Lacticaseibacillus paracasei subsp. paracasei F19 as a Model Probiotic for Functional Fermented Beverages: Survival Mechanisms, Bioactive Production, and Therapeutic Potential

Functional fermented beverages represent promising dietary tools for modulating nutrient-responsive pathways and intestinal homeostasis. The probiotic strain Lacticaseibacillus paracasei subsp. paracasei F19 (F19) has demonstrated exceptional resilience in technologically harsh environments, including high-hopped beers, acidic dairy matrices, and polyphenol-rich fruit substrates. Evidence from multi-omics analyses indicates that F19 activates hop- and acid-resistance systems while maintaining metabolic functions responsible for folate biosynthesis, short-chain fatty acid production, and the generation of bioactive volatiles. These metabolites participate in host-directed mechanisms, including the upregulation of the vitamin D receptor (VDR), modulation of autophagy-related genes such as ATG16L1, and attenuation of inflammatory signaling. Complementary studies using red pitaya (Hylocereus sp.) fermented with F19 and Bifidobacterium animalis subsp. lactis BB-12 further demonstrate increased VDR and CAMP expression, reduced CYP24A1, and the enrichment of anti-inflammatory flavonoids such as rutin and quercetin. Collectively, these findings support the concept of a probiotic paradox, in which environmental stressors do not suppress probiotic function but instead enhance genetic, metabolic, and host-interactive capacities. F19 thus emerges as a compelling candidate for the development of functional fermented foods aimed at improving epithelial barrier integrity, modulating immune responses, and supporting microbiota equilibrium, with translational potential for managing inflammatory and nutrient-responsive intestinal disorders.